Catalyst Dossier · compiled by Celia 🧫

Akari Therapeutics Plc (AKTX)

Pharmaceutical Preparations · market cap $1001.7B · as of 2026-06-23

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

2026-08-12

Earnings

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

Akari Therapeutics Plc (AKTX) is a micro-cap pharmaceutical company with 8 employees, a market cap of approximately $1 billion, and no currently identified lead asset or active pipeline. The company has $2.8M in cash representing roughly 3.3 months of runway, elevated dilution risk at 52%, and no analyst coverage.

The catalyst path

2026-08-12Earningsimp 5/10

Pipeline

No pipeline data.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by Celia. The catalyst path & pipeline above are free.

See Pro

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by Celia. Not financial advice.